2-(4-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane CAS= [195062-61-4] 2-Phenyl-2,3-dihydro-1H-naphtho [1,8-de] P NMR were recorded on 300 MHz Avance I and 400 MHz Avance II spectrometers. The chemical shifts (δ) and coupling constants (J) are expressed in ppm and hertz respectively. The following abbreviations were used to explain the multiplicities: s = singlet, d =doublet, m = multiplet.
Chemicals were purchased from Sigma-Aldrich or Alfa Aesar. All catalytic reactions were carried out under argon atmosphere unless specified. All chemicals were stored under argon. Acetonitrile were distilled over CaH 2 . Silica gel (230-400 mesh) purchased from Merck was used for flash chromatography. Analytical TLC silica gel 60 F254 were used
General Procedures

General Procedure A : Transformation of Potassium Trifluoro(organo)borates into Boronic Acids
To a solution of potassium aryltrifluoroborate (1 mmol) in distilled H 2 O (4 mL) was added, sequentially, a solution of FeCl 3 (8 mg, 0.05 mmol, 5 mol%) in H 2 O (1 mL) and imidazole (204 mg, 3 mmol). The resulting colourless solution was stirred at room temperature for 15 min. The reaction was then diluted with H 2 O (5 mL) and extracted with Et 2 O (3 x 8 mL). The combined organic extracts were dried (Na 2 SO 4 ) and concentrated in vacuo, affording pure product without the requirement for further purification.
General Procedure B : Transformation of Boronic Acids into Boronates
To a solution of aryl boronic acid (1 mmol) in MeCN (4 mL) was added, sequentially, a solution of FeCl 3 (8 mg, 0.05 mmol, 5 mol%) in H 2 O (1 mL), imidazole (204 mg, 3 mmol) and pinacol (118 mg, 1 mmol). The resulting cloudy orange mixture was stirred at room temperature for 30 min. The reaction was then diluted with H 2 O (5 mL) and extracted with Et 2 O (3 x 8 mL). The combined organic extracts were dried (Na 2 SO 4 ) and concentrated in vacuo. The resulting oil was then purified by a filtration through a silica gel plug (eluting with Et 2 O), affording the title compound.
General Procedure C : Synthesis of Diazaborinane from Boronic Acids
To a solution of aryl boronic acid (1 mmol) in MeCN (4 mL) was added, sequentially, a solution of FeCl 3 (8 mg, 0.05 mmol, 5 mol%) in H 2 O (1 mL), imidazole (204 mg, 3 mmol) and 1,8-diaminonaphthalene (159 mg, 1 mmol). The resulting cloudy, dark purple mixture was stirred at room temperature for 2h. The reaction was then diluted with H 2 O (5 mL) and extracted with EtOAc (3 x 8 mL). The combined organic extracts were dried (Na 2 SO 4 ) and concentrated in vacuo. The resultant viscous purple oil was then purified by a filtration through a silica gel plug (eluting with Et 2 O), affording the title compound.
General Procedure D: Synthesis of Diazaborolane from trifluoroborates
To a solution of potassium trifluorophenylborate (184 mg, 1 mmol) in distilled H 2 O (4 mL) was added, sequentially, a solution of FeCl 3 (8 mg, 0.05 mmol, 5 mol%) in H 2 O (1 mL), imidazole (204 mg, 3 mmol) and pinacol (118 mg, 1 mmol) . The resulting dark yellow solution was vigorously stirred at room temperature for 15 min. The reaction was then diluted with H 2 O (5 mL) and extracted with Et 2 O (3 x 8 mL). The combined organic extracts were dried (Na 2 SO 4 ) and concentrated in vacuo. The resulting oil was then purified by a filtration through a silica gel plug (eluting with Et 2 O), affording 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane. 4,4,5,5-Tetramethyl-2-phenyl-1,3,2-dioxaborolane was prepared according to the general procedure B, affording the title compound as a pale yellow oil, which solidified upon standing; 86% yield, 4,4,5,5-Tetramethyl-2-phenyl-1,3,2-dioxaborolane was prepared according to the general procedure D, affording the title compound as a pale yellow oil, which solidified upon standing; 65% yield, 1 
4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenol
Following the general procedure B using 138mg of (4-hydroxyphenyl)boronic acid, 145 mg of 4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenol were obtained as a white solid. 70% yield. Following the general procedure B using 225mg of (3-(methoxycarbonyl)-5-nitrophenyl)boronic acid, 239mg of methyl 3-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-5-nitrobenzoate were obtained as a white solid. 82% yield. 303mg of tert-butyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate were prepared according to the general procedure B, using 221mg of (4-((tertbutoxycarbonyl)amino)phenyl)boronic acid affording the title compound as a white solid; 81% yield 1 H NMR (300 MHz, CDCl 3 ) δ 7.71 (dd, J = 10.0, 8.3 Hz, 1H), 7.36 (dd, J = 8.5 Hz, 1H), 1.51 (s, 3H), 1.33 (s, 5H). 11 B NMR (96 MHz, CDCl 3 ) δ 30.8 (s).
13
C NMR (75 MHz, CDCl 3 ) δ 152. 6, 141.3, 136.0, 135.2, 122.1, 117.4, 83.8, 80.8, 28.4, 25 .0. 1, 166.1, 163.5, 142.2, 142.1, 140.0, 117.3, 116.9, 116.7, 84.7, 25.0. 19 Hz), 7.26 (2H, t, J 7.7 Hz), 7.51-7.60 (3H, m), 7.70 (2H, dd, J 1.6 Hz, 7.8 Hz).
C NMR (50 MHz, CDCl 3 ) δ 106. 2, 118.0, 130.0, 128.0, 128.4, 130.4, 131.6, 136.5, 141.2. 11 B NMR (96 MHz, CDCl 2, 118.1, 120.0, 127.7, 128.5, 132.9, 136.39, 136.45, 140.9. 11 6, 106.0, 117.8, 117.9, 127.7, 129.1, 131.5, 136.4, 140.4 9, 117.7, 120.0, 126.9, 127.7, 128.8, 136.5, 137.7, 141 8, 142.4, 135.9, 135.2, 128.7, 127.6, 123.3, 119.7, 119.5, 116.9, 116.1, 105.6 
